The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
ASE Technology Holding CoLtd ADR ASX
Clears the common standard
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · ASE Technology Holding Co., Ltd., together with its subsidiaries, provides semiconductor manufacturing services in the United States, Taiwan, rest of Asia, Europe, and internationally.
read at $36.84
ASE Technology Holding CoLtd ADR holds its Markup at $36.84.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 12 days |
| Price | $36.84 |
| Valuation | 58.48 trailing · 18.94 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.46 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 17.20% |
| Profit margin | 7.04% |
| Debt to equity | 67.16 |
| Analyst consensus | Strong Buy · 2 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
It depends which standard you follow. There are two widely recognised ways to check whether a company is suitable for a Muslim investor, and on this company they disagree. Here is how it did on each:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✓ PASSES
Why the two disagree. They fall out over one thing only: the company’s debt. Our stricter standard measures that debt against what the company owns, and it works out too high to pass. The common standard measures the same debt against what the company is worth on the stock market, where it works out low enough to pass. Every other check, the two agree on. So in practice, most halal apps would treat this as fine to hold, while our stricter view would not — and which line you follow is between you and your scholar.
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Against market value it is 316.7%, under the 30% line the market-value standard uses — so that standard clears it. Divergent
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Chip packaging cycles offer no margin of safety
Every wafer that leaves the fab still needs someone to slice it, case it and test it before the phones or servers hit the shelves. ASE sits at that unglamorous step in the chain, turning raw silicon into finished packages for clients across Asia and beyond.
We pass because the shares sit above our fair value with a forward multiple that leaves no buffer once the cycle turns. Revenue growth of 17 percent looks respectable yet a 7 percent profit margin and narrow moat give little protection when utilisation falls, exactly the pattern that defines this industry.
The real risk lies in the cyclical value trap. Peak earnings often arrive with peak multiples that later compress sharply, while Taiwan currency swings and customer concentration can erode returns faster than the 14 percent ROE suggests. Analysis, not advice.
| Forward P/E | 18.9x fairly priced for its growth rate |
| Trailing P/E | 58.5x expensive — the price assumes strong growth ahead |
| Revenue growth | 17.2% steady growth |
| Profit margin | 7.0% thin but positive margins |
| Return on equity | 13.6% a solid return on shareholder capital |
| Debt to equity | 0.67 moderate, manageable leverage |
| Current ratio | 1.15 adequate liquidity, worth monitoring |
| Beta | 1.46 moves a little more than the market |
| Market cap | $80.8B |
| Employees | 107,950 |
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Taiwan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on ASX
- › You May Not Know ASE Technology, But the Chip Stock Has Nearly Quadrupled Barchart · 16d ago
- › ASML Holding's Q2 Earnings Beat Estimates, Revenues Rise Y/Y Zacks · 16d ago
- › Aehr Test Systems' Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks · 17d ago
- › ASX vs. LRCX: Which AI Semiconductor Stock is the Better Buy? Zacks · 17d ago
- › Premium Smartphone Demand Holds Up: What's Ahead for Amkor Technology? Zacks · 19d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in ASX's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 95% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 251%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (2 analysts) rates it strong buy, with a mean price target of $36.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $35.30 | -2.6% | · | $974 | -2.6% |
| 2 months | $24.84 | +38.5% | · | $1,385 | +38.5% |
| 3 months | $20.99 | +63.8% | · | $1,638 | +63.8% |
| 6 months | $16.40 | +109.7% | · | $2,097 | +109.7% |
| 1 year | $9.79 | +251.3% | $0.36 | $3,550 | +255.0% |
| 2 years | $10.44 | +229.5% | $0.68 | $3,359 | +235.9% |
| 3 years | $7.60 | +352.8% | $1.25 | $4,692 | +369.2% |
| 5 years | $6.78 | +407.0% | $2.03 | $5,369 | +436.9% |
Historical returns from market close data. Past performance does not guarantee future results.